1-bromo-adamantane

1-bromo-adamantane
Product Description

Tianjin minxiang pharmaceutical offers wide range of api, intermediates, & medical devices products which includes 1-bromo-adamantane. It belongs to intermediate series. Contact us for more information.

Read more Show less

Tianjin Minxiang Pharmaceutical Co., Ltd

  • CN
  • 2015
    On CPHI since
  • 2
    Certificates
  • 250 - 499
    Employees
Company types
Manufacturer/Innovator
Primary activities
API Producer
View company profile
Categories
more categories Show less
Specifications
  • Selling Points
    Brand Name; Experienced Technicians
  • Supplied from
    China
More specifications Fewer specifications
Sales Markets
Show more Show less

Tianjin Minxiang Pharmaceutical Co., Ltd

  • CN
  • 2015
    On CPHI since
  • 2
    Certificates
  • 250 - 499
    Employees
Company types
Manufacturer/Innovator
Primary activities
API Producer
View company profile

More Products from Tianjin Minxiang Pharmaceutical Co., Ltd (4)

  • (r) - pyrrolidine-2-carbonitrile hydrochloride

    Product (r) - pyrrolidine-2-carbonitrile hydrochloride

    Tianjin minxiang pharmaceutical offers wide range of api, intermediates, & medical devices products which includes (r) - pyrrolidine-2-carbonitrile hydrochloride. It belongs to intermediate series. Contact us for more information.
  • (s) - pyrrolidine-2-carbonitrile hydrochloride

    Product (s) - pyrrolidine-2-carbonitrile hydrochloride

    Tianjin minxiang pharmaceutical offers wide range of api, intermediates, & medical devices products which includes (s) - pyrrolidine-2-carbonitrile hydrochloride. It belongs to intermediate series. Contact us for more information.
  • 1-Bromoadamantane

    Product 1-Bromoadamantane

    welcome to contact us
  • 1,3-dimethyl adamantane

    Product 1,3-dimethyl adamantane

    Tianjin minxiang pharmaceutical offers wide range of api, intermediates, & medical devices products which includes 1,3-dimethyl adamantane. It belongs to intermediate series. Contact us for more information.